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Abstract. 
 
We have examined the regulation of p21
 
cip1
 
 
by soluble mitogens and cell anchorage as well as the 
relationship between the expression of p21
 
cip1
 
 and acti-
vation of the ERK subfamily of MAP kinases. We ﬁnd 
that p21
 
cip1
 
 expression in G1 phase can be divided into 
two discrete phases: an initial induction that requires 
growth factors and the activation of ERK, and then a 
subsequent decline that is enhanced by cell anchorage 
in an ERK-independent manner. In contrast to the in-
duction of cyclin D1, the induction of p21
 
cip1
 
 is medi-
ated by transient ERK activity. Comparative studies 
with wild-type and p21
 
cip1
 
-null ﬁbroblasts indicate that 
adhesion-dependent regulation of p21
 
cip1
 
 is important 
for proper control of cyclin E–cdk2 activity. These data 
lead to a model in which mitogens and anchorage act in 
a parallel fashion to regulate G1 phase expression of 
p21
 
cip1
 
. They also show that (a) growth factors and 
growth factor/extracellular matrix cooperation can 
have different roles in regulating G1 phase ERK activ-
ity and (b) both transient and sustained ERK signals 
have functionally signiﬁcant roles in controlling cell cy-
cle progression through G1 phase.
Key words: cell cycle • adhesion • ECM • MAP
kinase • cdk inhibitors
 
T
 
HE
 
 majority of cells in the adult are thought to be in
a resting quiescent state. When suitable extracellu-
lar cues are present, e.g., during a response to in-
jury, cells leave this quiescent (G0) state and enter the G1
phase of the cell cycle. For most cell types, the extracellu-
lar cues that mediate progression through G1 phase can be
divided into two general groups: soluble mitogenic growth
factors and the extracellular matrix (ECM)
 
1
 
 (reviewed in
Assoian, 1997). The signaling potential of soluble mito-
gens and the ECM results from their ability to bind to and
cluster specific cell surface receptors, typically receptor ty-
rosine kinases (RTKs) and integrins, respectively.
When RTKs and integrins are signaling, cells undergo a
series of molecular events involving cyclins, cyclin-depen-
dent kinases (cdks), and cdk inhibitors (CKIs) (reviewed
in Hunter and Pines, 1994; Sherr, 1994; Sherr and Roberts,
1995). Two cyclin-cdk activities, cyclin D–cdk4/6 and cy-
clin E–cdk2, are required for progression of cells through
 
G1 phase. In large part, these enzymes are required
because they phosphorylate the retinoblastoma protein
(pRb); this event allows for the release of E2F and the in-
duction of E2F-regulated genes such as cyclin A (Wein-
berg, 1995). The induction of cyclin A, with consequent
formation of active cyclin A–cdk2 complexes, is thought to
reflect entry into S phase of the cell cycle.
In fibroblasts and epithelial cells, mitogens and the
ECM are jointly required to induce the expression of cy-
clin D1 mRNA (Böhmer et al., 1996; Zhu et al., 1996; Day
et al., 1997; Radeva et al., 1997; Resnitzky, 1997). This ef-
fect has been linked to sustained ERK activity and the role
of integrin signaling in sustaining ERK activity throughout
G1 phase (Weber et al., 1997; Roovers et al., 1999). The
translation of cyclin D1 mRNA is also dependent upon
cell adhesion (Zhu et al., 1996; Huang et al., 1998). The
combined mitogen/anchorage requirement for expression
of cyclin D1 explains, in part, why hyperphosphorylation
of pRb and expression of cyclin A are also jointly depen-
dent upon exposure of cells to mitogens and an ECM.
In addition to their cooperative effects in the induction
of cyclin D1, mitogens and the ECM are also jointly re-
quired for activation of cyclin E–cdk2 (reviewed in As-
soian, 1997). The cyclin E–cdk2 complexes harvested from
suspended cells are catalytically inactive when assayed in
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vitro despite the fact that the cells had been exposed to
growth factors. Suspended cells express elevated levels of
two CKIs, p21
 
cip1
 
 and p27
 
kip1
 
, and the catalytically inactive
cyclin E–cdk2 complexes isolated from suspended cells
show increased association of both p21
 
cip1
 
 and p27
 
kip1
 
. Nei-
ther CAK activity nor the levels of cyclin E and cdk2 are
significantly different in adherent vs. nonadherent cells, so
it seems likely that mitogens and anchorage jointly regu-
late cyclin E–cdk2 activity by controlling the expression of
p21
 
cip1
 
 and p27
 
kip1
 
. Changes in p21
 
cip1
 
 expression are often
associated with altered transcription of the gene, whereas
changes in p27
 
kip1
 
 levels have typically been associated
with changes in protein translation or degradation (Hengst
and Reed, 1996; Sheaff et al., 1997; Montagnoli et al.,
1999). Thus, very different mechanisms likely underlie the
effects of growth factors and the ECM on p21
 
cip1
 
 and
p27
 
kip1
 
 levels.
In this study, we have examined the regulation of p21
 
cip1
 
.
p21
 
cip1
 
 is poorly expressed in quiescent cells, it is rapidly
induced when cells are stimulated with mitogens, and its
expression then declines as cells reach mid-late G1 phase
(Li et al., 1994; Macleod et al., 1995; Liu et al., 1996; Bosch
et al., 1998). The early G1 phase induction of p21
 
cip1
 
 plays
a role in the assembly of cyclin D–cdk4/6 complexes (La-
Baer et al., 1997; Cheng et al., 1999), and the mid-late G1
phase decline of p21
 
cip1
 
 correlates with activation of cyclin
E–cdk2. p53 is important for induction of the p21
 
cip1
 
 pro-
moter (El-Deiry et al., 1993), but p53-independent mecha-
nisms also induce the p21
 
cip1
 
 gene (Macleod et al., 1995;
Zeng et al., 1996). In fact, activation of ERKs has been
strongly implicated in the induction of p21
 
cip1
 
 (Liu et al.,
1996; Pumiglia and Decker, 1997; Auer et al., 1998).
We report here that p21
 
cip1
 
 expression can be divided
into two discrete phases: an initial induction that requires
mitogens and ERK activity and a subsequent downregula-
tion that is enhanced by cell anchorage and independent
of ERK activity. Thus, growth factors and the ECM act in
parallel to regulate the expression of p21
 
cip1
 
 during G1
phase. We also report that, in contrast to the regulation of
cyclin D1, a transient activation of ERK is sufficient to in-
duce p21
 
cip1
 
.
 
Materials and Methods
 
Cell Culture
 
Established mouse embryo fibroblasts (MEFs) from wild-type, p21
 
cip1
 
-
null, and p53-null C57B6J mice were generous gifts from Jim Roberts
(Fred Hutchinson Cancer Research Center, Seattle, WA) and Tyler Jacks
(MIT, Cambridge, MA). The cells had been maintained on a standard
3T3-like protocol which resulted in establishment of MEF cell lines. For
G0-synchronization, MEFs were brought to confluence, washed, and then
cultured in serum-free DME or defined medium (see below) for 2 d. To
stimulate entry into the cell cycle, G0-synchronized cells were trypsinized,
suspended in 10% FCS-DME, and reseeded on tissue culture dishes
(monolayer) or agarose-coated petri dishes (suspension) using 2 
 
3
 
 10
 
6
 
cells per 100-mm dish
 
 
 
similarly to the procedure described in Böhmer et
al. (1996). To study the relative effects of growth factors and fibronectin,
trypsinized quiescent cells (2 
 
3
 
 10
 
6
 
 cells) were suspended in 10 ml defined
medium (1:1 DME: Hams F-12, 15 mM Hepes, pH 7.4, 3 mM histidine, 4
mM glutamine, 8 mM sodium bicarbonate, 10 
 
m
 
M ethanolamine, 10 
 
m
 
g/ml
transferrin, 0.1 
 
m
 
M sodium selenite, 0.1 
 
m
 
M MgCl
 
2
 
, and 1 mg/ml BSA).
Some of the cells were treated with a cocktail of purified growth factors
(10 ng/ml PDGF, 1 
 
m
 
M insulin, and 2 nM EGF) that allowed for optimal
induction of p21
 
cip1
 
. Cells were then plated on 100-mm dishes that had
 
been coated (16 h at 4
 
8
 
C) with fibronectin (100 
 
m
 
g) or 2 mg/ml fatty acid–
free, heat-inactivated BSA in PBS (which blocks cell adhesion in se-
rum-free culture). Coating with fibronectin or BSA was performed as
described (Zhu et al., 1999). In experiments with UO126 (Promega),
G0-synchronized cells in 100-mm dishes were directly stimulated with pu-
rified growth factors in defined medium. For all experiments, cells were
washed 2–3 times with PBS, collected by scraping (monolayer cultures) or
low-speed centrifugation (suspension cultures), and extracted for North-
ern blotting, luciferase assays, and immunoblotting, or immunoprecipita-
tion and in vitro kinase assays. In studies using serum as the mitogenic
stimulus, the extracts of quiescent cells were prepared before incubation
of the cells in monolayer or suspension. For studies in defined medium,
extracts of quiescent cells (in growth factor-free defined medium) were
prepared both before and after incubation of the cells in monolayer and
suspension; similar results were obtained from both controls. Note that
MEFs attached to fibronectin and cultured with growth factors in defined
medium remained well spread for up to 12 h.
To study the consequence of ERK activation in suspended cells, we
used NIH-3T3 cells stably transfected with a constitutively active MEK-1
(S218D/S222D) in a tetracycline-repressible expression system (Roovers
et al., 1999). The transfectants were maintained at 
 
,
 
50% confluence in
DME, 10% calf serum, 0.5 mg/ml G418, and 0.4 mg/ml hygromycin. Tetra-
cycline (2 
 
m
 
g/ml) was added daily.
 
Analysis of p21
 
cip1
 
 Promoter Activity
 
MEFs (1.5 
 
3
 
 10
 
5
 
 in 2 ml DME, 10% FCS) were plated in 35-mm dishes and
incubated overnight. The resulting monolayers (
 
z
 
80% confluent) were
washed with DME before transient cotransfection with 1 
 
m
 
g of p21
 
cip1
 
 pro-
moter-luciferase plasmid (0-luc; gift of Wafik El-Deiry), 0.1 
 
m
 
g of the re-
nilla luciferase expression plasmid, pRL-SV40 (Promega), and 5 
 
m
 
l lipo-
fectamine (Life Technologies) in a total volume of 1 ml serum-free DME
without antibiotics. After a 5-h incubation, 1 ml of 20% FCS-DME was
added to each well and the cultures were incubated overnight. 18 h after
transfection, the cells were G0-synchronized by 2-d incubation in serum-
free DME. After trypsinization, an aliquot of the cells was removed for de-
termination of p21
 
cip1
 
-promoter activity at quiescence; the remainder was
resuspended in 10% FCS-DME and then replated in 100-mm dishes
(0.5–1 
 
3
 
 10
 
5
 
 cells/10 ml) in monolayer and suspension. At selected times,
cells were washed, collected, and extracted in 50 
 
m
 
l of Passive Lysis Buffer
(Promega) before analysis of firefly luciferase and renilla luciferase activity
using the Dual-Luciferase reporter assay system (Promega). p21
 
cip1
 
 pro-
moter activity was normalized to a constant amount of renilla-based lumi-
nescence to correct for differences in transfection efficiency.
 
Other Procedures and Reagents
 
Northern blotting, immunoprecipitations, and in vitro kinase assays were
performed as described (Zhu et al., 1996). Immunoblotting for pRb, cy-
clins, MEK, and ERKs was performed as described (Zhu and Assoian,
1995; Zhu et al., 1996) after fractionation of cell lysates on reducing SDS
gels containing 7.5% acrylamide. Immunoblotting for CKIs was per-
formed similarly except that the gels contained 15% acrylamide. The pro-
tein concentration of cell lysates destined for immunoblot analysis was de-
termined by Coomassie binding (BioRad Protein Assay), and equal
amounts (100 
 
m
 
g for the analysis of cyclins, cdks, and CKIs, and 25 
 
m
 
g for
the analysis of MEK* and ERK) were fractionated on SDS gels. Cells des-
tined for immunoblot analysis with anti-ERK or anti-phospho-ERK anti-
bodies were extracted as described (Zhu et al., 1999).
Rabbit polyclonal antiserum against cyclin A was prepared in this labora-
tory, and the antiserum to p21
 
cip1
 
 was the generous gift of Claudio Schneider
(AREA Science Park, Trieste, Italy). All other antisera were purchased:
anti-cyclin E (sc-481) and anti-cdk4 (sc-260) from Santa Cruz Biotechnology;
anti-cyclin D1 (06-137), and anti-cdk2 (06-505) from Upstate Biotechnol-
ogy; anti-MEK-1 (M17020), anti-p27
 
kip1
 
 (K25020), and anti-ERK (M12320)
from Transduction Laboratories, anti-pRb (100601) from Ciba-Corning; and
anti-phospho-ERK (9101S) from New England BioLabs.
 
Results
 
G1 Phase Induction of p21
 
cip1
 
 Requires Growth Factors, 
Does Not Require Cell Adhesion, and Is Dependent 
upon the Activation of ERKs
 
Our initial studies compared the temporal expression pat- 
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tern of p21
 
cip1
 
 when adherent and nonadherent MEFs
were exposed to mitogens (Fig. 1 A). Consistent with stud-
ies by others (see above), we find that the level of p21
 
cip1
 
 is
low in quiescent MEFs, strongly induced within a few
hours after exposure of adherent MEFs to mitogens (refer
to 3 h, monolayer), and then declines to a barely detect-
able level (refer to 12 h, monolayer) as the cells progress
into mid-late G1 phase. However, we also observed that
if MEFs are stimulated with mitogens in the absence of
substratum, the initial induction of p21
 
cip1
 
 is preserved
(3 h, suspension) while the subsequent downregulation is
incomplete (compare monolayer and suspension cells at
12 h).
Addition of purified growth factors to quiescent MEFs
in serum-free medium (Fig. 1 B) also resulted in a strong
induction of p21
 
cip1
 
 (similar to that seen with serum), and
the degree of induction was similar whether cells were cul-
tured on a substratum or in suspension (compare Mn to Sp
and Fn
 
1
 
GFs to BSA
 
1
 
GFs). Moreover, p21
 
cip1
 
 was not in-
duced when MEFs were cultured on fibronectin-coated
dishes in the absence of growth factors (Fn-GFs). These
results strongly argue that growth factors, and not adhe-
sion factors in serum, are responsible for the early G1
phase induction of p21
 
cip1
 
. Together, the results of Fig. 1,
A and B, indicate that G1 phase regulation of p21
 
cip1
 
 can
be divided into two discrete phases: an initial induction
that is mediated by mitogens and a subsequent downregu-
lation that is enhanced by cell adhesion to substratum.
Consistent with studies implicating ERK activation in
the induction of p21
 
cip1
 
 (see above), we found that the new
generation MEK inhibitor, U0126 (Favata et al., 1998)
completely blocked the induction of p21
 
cip1
 
 when quies-
cent MEFs were treated with purified growth factors (Fig.
2 A). This effect was associated with the inhibition of ERK
activation (determined by direct detection of phospho-
ERK and ERK2 gel-shift). Treatment with rapamycin (a
potent inhibitor of p70S6 kinase; Price et al., 1992) or
LY294002 (a specific PI 3-kinase inhibitor; Vlahos et al.,
1994) did not inhibit the activation of ERK or the induc-
tion of p21
 
cip1
 
 (Fig. 2 A). Thus, activation of the MEK/
ERK pathway is necessary for the induction of p21
 
cip1
 
 by
growth factors. NIH-3T3 transfectants expressing a consti-
tutively active MEK-1 (MEK*) under control of a tetra-
cycline-repressible promoter (tet-MEK*-3T3 cells) were
then used to determine if activation of the MEK/ERK
pathway would be sufficient to induce p21
 
cip1
 
. Suspended
MEFs were incubated in the presence and absence of tet-
racycline and a minimal mitogenic stimulus (0.5% serum,
which permitted the synthesis of MEK* in the absence of
tetracycline). In the presence of tetracycline, 0.5% serum
had a small effect on ERK activation (assessed by direct
detection of phospho-ERK) and little effect on the expres-
sion of p21
 
cip1
 
 (Fig. 2 B; compare G0 to 
 
1
 
tet). In the ab-
sence of tetracycline, MEK* was induced, resulting in a
strong phosphorylation of ERKs and an induction of
p21
 
cip1
 
 (Fig. 2 B; compare G0 to 
 
2
 
tet). Thus, MEK* is suf-
ficient to induce p21
 
cip1
 
 in the absence of both cell anchor-
age and a strong mitogenic stimulus. This result supports
other studies showing that expression of constitutively ac-
tive raf results in the induction of p21
 
cip1
 
 (Lloyd et al.,
1997; Pumiglia and Decker, 1997; Sewing et al., 1997;
Woods et al., 1997; Auer et al., 1998; Kerkhoff and Rapp,
1998).
 
Transient ERK Activity Induces p21
 
cip1
 
Next we examined the relationship between the duration
of an ERK signal and the induction of p21
 
cip1
 
. Addition of
purified growth factors to MEFs in serum-free culture in-
duced a complete activation of ERKs (determined by gel-
shift and direct measurement of phospho-ERK) in both
nonadherent and adherent cells (Fig. 3 A, compare BSA
with FN at 1 h). However, ERK activity declined in sus-
pended cells while it was sustained in adherent cells (Fig. 3
A, compare BSA with FN at 3 h). p21
 
cip1
 
 was induced to
the same degree in both the suspended and adherent cells
(at 1–3 h in several independent experiments). In several
experiments, the analysis of ERK activity by gel-shift, im-
munoblotting with an anti-phospho-ERK (specific for the
dually phosphorylated form) and in vitro kinase assays
(not shown) all demonstrated that transient ERK activity
can be induced by growth factors in suspended cells while
Figure 1. Biphasic regulation of p21cip1 expression by growth fac-
tors and the extracellular matrix. In A, G0-synchronized MEFs
were seeded in suspension and monolayer in 10% FCS-DME and
incubated for 0–12 h. Cell extracts were prepared and equal
amounts of protein were fractionated on reducing SDS gels and
analyzed by immunoblotting and enhanced chemiluminescence
(ECL) using antibodies against p21cip1 and cdk2 (a control for
loading). [Note: In this experiment the downregulation of p21
was essentially complete in 12 h, but other experiments indicate
that strong downregulation usually occurs over a 12–18-h period.]
In B, quiescent MEFs (G0) were cultured for 3 h in defined me-
dium on dishes coated with BSA or fibronectin (Fn). The incuba-
tions were also performed in the absence (2GF) or presence
(1GF) of purified growth factors. Duplicate cultures were incu-
bated in monolayer (Mn) and suspension (Sp) in 10% FCS-DME
for comparison. Collected cells were analyzed by immunoblot-
ting with anti-p21cip1 and anti-cdk4 (a control for loading). 
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sustained ERK activity requires both growth factors and
cell anchorage. Our interpretation of these results is that a
transient ERK activation is sufficient to induce p21
 
cip1
 
.
These results also indicate that the induction of p21
 
cip1
 
 is
anchorage-independent because transient ERK activation
does not require cell adhesion to substratum (see below).
Note that the induction of cyclin D1, which requires a sus-
tained ERK activation (Weber et al., 1997), does not occur
when suspended MEFs (Fig. 3 B), NIH-3T3 cells (Zhu et
al., 1996), or normal human fibroblasts (Zhu et al., 1996)
are stimulated with mitogens.
Interestingly, a mitogen dose response curve showed
that when MEFs are stimulated with our standard growth
factor cocktail, fibronectin was not necessary for efficient
activation of ERK (Fig. 3 C, compare ERK activation on
BSA and fibronectin using the maximal concentration of
growth factors). However, lower growth factor concentra-
tions that partially activated ERK in suspended cells did
activate ERK completely when the cells were attached to
fibronectin (Fig. 3 C; compare ERK activation on BSA
and fibronectin using the low and intermediate concentra-
Figure 2. Activation of ERKs controls induction of p21cip1 by mi-
togens. In A, G0-synchronized MEFs (G0) were washed and pre-
incubated for 30 min in 10 ml defined medium with 100 mM
U0126, 5 nM rapamycin (R), 25 mM LY294002 (LY), or solvent
(dimethylsulfoxide) as control (–). Purified growth factors were
directly added to the cultures. The cells were incubated for 1 h
before collection and lysis. Equal amounts of cell extracts were
analyzed by immunoblotting using antibodies against p21cip1,
phospho-ERK (p-ERK), and ERK. Controls (not shown) dem-
onstrated that the concentrations of LY294002 and rapamycin we
used completely inhibited phosphorylation of p70S6 kinase. In B,
tet-MEK*-3T3 cells were grown to confluence in 10% FCS-DME
with 2 mg/ml tetracycline. The medium was removed, replaced
with serum-free DME, and the cultures were serum-starved for
1 d in the absence of tetracycline (G0). Serum-starved cells were
trypsinized and reseeded (2 3 106 in 10 ml 0.5% FCS) in 100-mm
agarose-coated dishes in the absence and presence of tetracycline
(tet). Cells were collected after 9 h and lysed. Equal amounts of
protein were fractionated on an SDS gel and analyzed by immu-
noblotting with Mek-1, phospho-ERK (p-ERK), ERK and
p21cip1 antibodies. For both panels, upper and lower arrows in the
ERK blots show the phosphorylated and unphosphorylated
ERK2, respectively.
Figure 3. Anchorage-independent induction of p21cip1 is associ-
ated with a short-term activation of ERK. In A, quiescent MEFs
were trypsinized, suspended in defined medium, and reseeded on
BSA- or fibronectin (FN)-coated dishes for 1 and 3 h in the pres-
ence of purified growth factors. Cells were collected, lysed, and
analyzed by immunoblotting with anti-ERK (top), anti-phospho-
ERK (middle panel), and anti-p21cip1. In B, MEFs were rendered
quiescent, trypsinized, suspended in 10% FCS-DME, and re-
seeded in monolayer and suspension for 0–12 h. Cells were col-
lected, lysed, and analyzed by immunoblotting using antibodies
to ERK and cyclin D1. In C, quiescent MEFs were trypsinized,
suspended in defined medium, and reseeded on BSA- or fi-
bronectin-coated dishes for 1 h in the presence of increasing con-
centrations of purified growth factors (the triangles represent a
dose-response curve of a PDGF-insulin-EGF cocktail used at 25,
50, and 100% of the concentration described in Materials and
Methods). For all panels, upper and lower arrowheads in the
ERK blots show the phosphorylated and unphosphorylated
ERK, respectively. 
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tion of growth factors). Fibronectin alone minimally acti-
vated ERK under these conditions (data not shown).
These results confirm other studies showing that fibronec-
tin and growth factors can synergize to regulate ERK ac-
tivity (see Discussion), but also show that growth factors
alone can fully activate ERK if cells are provided with a
sufficiently strong mitogenic stimulus. We emphasize,
however, that this strong mitogenic stimulus allows for
transient, but not sustained, ERK activation in suspended
cells (refer to Fig. 3 A).
To assess directly the duration of the ERK signal that is
required for the induction of p21
 
cip1
 
, we activated ERK by
stimulating quiescent MEFs with purified growth factors
in defined medium and then treated the cultures with
UO126 at 10, 20, and 40 min before collection at 1 h. Im-
munoblot analysis showed that (a) growth factors induced
a complete activation of ERK by 10 min (Fig. 4 A), (b) this
effect persisted for at least 60 min (Fig. 4 A), and (c)
UO126 rapidly inhibited growth factor–dependent ERK
activation (with 
 
z
 
50 and 90% inhibition in 10 and 20 min,
respectively; Fig. 4 B). Importantly, the induction of
p21
 
cip1
 
 was completely blocked when UO126 was added ei-
ther 10 or 20 min after stimulation with growth factors, but
it was easily detected when UO126 was added after 40 min
(Fig. 4 C). Considering that the inhibitory effect of UO126
on ERK activation is complete within 20 min, we conclude
that an ERK signal of 40–60 min is sufficient to induce
p21
 
cip1
 
. The same experimental approach was applied to
the analysis of cyclin D1 expression, and the results
showed that cyclin D1 was not induced even when UO126
was added 60 min after growth factor stimulation. These
data support and extend the results of Fig. 3, directly dem-
 
onstrating that the ERK signal required for induction of
p21
 
cip1
 
 is transient relative to that required for the induc-
tion of cyclin D1.
 
Full Downregulation of p21
 
cip1
 
 in G1 Phase Is 
Dependent upon Cell Adhesion and Independent
of ERKs
 
After its initial induction, p21
 
cip1
 
 levels are strongly down-
regulated in mid-late G1 phase, and the completeness
of this effect requires cell adhesion to substratum (re-
fer to Fig. 1 A). To identify the basis by which adhesion
affects p21
 
cip1
 
 downregulation, we compared the stability
of p21
 
cip1
 
 protein by stimulating adherent and nonadher-
ent MEFs with 10% FCS (to induce p21
 
cip1
 
) before the
addition of cycloheximide. Immunoblot analysis was per-
formed on lysates of cells collected 0–120 min after addi-
tion of cycloheximide. The results showed that the half-life
of p21
 
cip1
 
 was 
 
z
 
30 min under both culture conditions (Fig.
5). We were unable to find antibodies suitable for confir-
mation of this result by immunoprecipitation of p21
 
cip1
 
from pulse–chase-labeled cells, but our results with cy-
cloheximide indicate that the turnover of p21
 
cip1
 
 is not
strongly affected by cell adhesion to substratum.
Consistent with the lack of a detectable effect on p21
 
cip1
 
stability, both mRNA and promoter analyses showed that
cell adhesion significantly enhances repression of p21cip1
gene expression. Northern blotting showed an initial in-
duction of p21cip1 mRNA in both adherent and nonadher-
ent MEFs (Fig. 6 A, 3 h). p21cip1 mRNA levels then de-
clined, but the decline was much more pronounced in
adherent cells (Fig. 6 A, 9 and 12 h). p21cip1 promoter-lucif-
Figure 4. A transient ERK signal induces p21cip1.
MEFs were G0-synchronized in defined medium
and stimulated with purified growth factors for
the times shown. In A, cells were collected, lysed,
and analyzed by immunoblotting with anti-ERK
(ERK), anti-phospho-ERK (p-ERK), anti-
p21cip1, and anti-cdk4 (loading control). In B, the
cells were pretreated with purified growth fac-
tors for 10 min (time 0) before the addition of
U0126 (100 mM final concentration). After incu-
bation with UO126 for 10–60 min, cells were col-
lected, lysed, and the degree of ERK activation
was determined by gel-shift and direct assess-
ment of dually phosphorylated ERK by immu-
noblotting with anti-ERK (ERK) and anti-phos-
pho-ERK (p-ERK), respectively. For A and B,
the upper and lower arrowheads in the ERK
blots show the phosphorylated and unphosphor-
ylated ERK2, respectively. In C, the G0-syn-
chronized cells were stimulated with purified
growth factors, and U0126 was added to the cul-
tures 10, 20, and 40 min after the stimulation
with growth factors. All cells were collected at 60
min (a time sufficient for p21cip1 induction in cells lacking UO126), lysed, and analyzed for the expression of p21cip1 by immunoblotting.
MEFs stimulated in the absence of U0126 for 60 min were used as a positive control (C) for the induction of p21cip1. In D, G0-synchro-
nized MEFs were stimulated with purified growth factors and U0126 was added to the cells 10, 20, 40, and 60 min after stimulation with
growth factors. All cultures were collected at 8 h (a time sufficient for cyclin D1 induction in cells lacking UO126), lysed and analyzed
for the expression of cyclin D1 by immunoblotting. MEFs stimulated in the absence of U0126 for 8 h were used as a positive control (C)
for the expression of cyclin D1 (detected as the doublet migrating slightly above cdk4). In C and D, immunoblotting with anti-cdk4 was
used to control for protein loading.The Journal of Cell Biology, Volume 146, 1999 1260
erase assays gave similar results (Fig. 6 B) except that
there was essentially no decline in promoter activity when
cells were cultured in suspension. This difference in p21cip1
promoter activity vs. p21cip1 mRNA or protein (refer to
Fig. 1 A) levels in suspended MEFs suggests that a consti-
tutive, anchorage-independent turnover of p21cip1 mRNA
may also play a role in setting the steady state level of
p21cip1 protein. Nevertheless, the combined results of Figs.
5 and 6 strongly indicate that changes in gene expression
play a major role in the adhesion-dependent repression (as
well as the growth factor–dependent induction) of p21cip1.
We examined the potential contribution of p53 in G1
phase regulation of p21cip1 gene expression by performing
Northern blots with MEFs derived from p53-null mice.
Consistent with many studies implicating p53 in the induc-
tion of the p21cip1 gene, we found that the levels of p21cip1
mRNA were generally reduced about three- to fivefold
when compared with those observed in wild-type MEFs
(not shown). However, the pattern of mitogen-dependent
induction and adhesion-enhanced repression was retained
in the p53-null MEFs (Fig. 7 A). Although this result does
not exclude a potential role for p53 in the ECM-depen-
dent downregulation of p21cip1 gene expression, it does
show that p53 is not required.
Since the induction of p21cip1 requires ERK activity, we
considered the possibility that the decay of ERK activity
was responsible for downregulating p21cip1 in mid-late G1
phase of adherent cells. However, this potential mecha-
nism is not compatible with the fact that p21cip1 is poorly
downregulated in suspended cells where the ERK signal
decays quickly. We then considered the possibility that sus-
tained ERK activity might be phosphorylating a repressor
of p21cip1 gene expression. To address this potential mecha-
nism, we forced sustained ERK activity in suspended cells
and asked if p21cip1 expression was repressed, as it would
be in monolayer cells. tet-MEK*-3T3 cells were cultured in
monolayer and suspension in the presence and absence
of tetracycline. We found that downregulation of p21cip1
failed to occur in the suspended cells, even when a sus-
tained ERK signal had been enforced (compare the p21cip1
and phosho-ERK signals in Fig. 7 B; Sp 6 tet). We con-
clude that the downregulation of p21cip1 resulting from cell
adhesion to ECM is independent of ERK.
Effect of p21cip1 on Anchorage-dependent
Cyclin E–cdk2 Activity
Cyclin E–cdk2 activity is not induced when fibroblasts are
Figure 5. Turnover of p21cip1 in adherent and
nonadherent cells. G0-synchronized MEFs were
trypsinized and replated in suspension or mono-
layer for 3 h with 10% FCS-DME before the ad-
dition of cycloheximide (10 mg/ml final concen-
tration). Cells were collected at the indicated
times spanning 120 min and lysed. Equal
amounts of protein were fractionated on SDS
gels and immunoblotted using anti-p21cip1 and
anti-cdk2 (loading control).
Figure 6. Full downregulation of p21cip1 gene expression requires
cell adhesion. In A, MEFs were rendered quiescent, trypsinized,
and then replated in monolayer (Mn) and suspension (Sp) in the
presence of 10% FCS-DME. At the times shown, cells were col-
lected and lysed for collection of RNA. Northern blotting was
performed using a 32P-labeled, random-primed probe for murine
p21cip1 and equal loading of samples was confirmed by ethidium-
bromide staining of rRNA (not shown). In B, MEFs were tran-
siently transfected with a p21cip1 promoter-luciferase construct as
described in Materials and Methods. Transfected cells were G0-
synchronized and stimulated with 10% FCS-DME in monolayer
and suspension for the times shown. B shows fold-induction of lu-
ciferase activity, relative to G0-synchronized cells and normal-
ized to constant activity of the Renilla luciferase control reporter
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treated with mitogens in the absence of a substratum, and
the lack of kinase activity correlates with an increased ex-
pression of p21cip1 and p27kip1 (reviewed in Assoian, 1997).
To determine if this increased expression of p21cip1 is caus-
ally related to the inhibition of cyclin E–cdk2 activity, we
asked if cyclin E–cdk2 activity would be anchorage inde-
pendent in suspended cells lacking p21cip1.
G0-synchronized MEFs derived from wild-type and
p21cip1-null mice were mitogen-stimulated in monolayer
and suspension before collection and analysis of cyclin
E–cdk2 kinase activity in vitro. As expected, the activation
of cyclin E–cdk2 was completely blocked when wild-type
MEFs were cultured in suspension (Fig. 8). In contrast, cy-
clin E–cdk2 activity was readily detectable in lysates from
suspended p21cip1-null cells, at z50% of the value seen in
lysates from the adherent p21cip1-null cells. (Because the
p21cip1-null and wild-type MEFs are independent isolates,
comparisons of cyclin E–cdk2 activity in lysates of quies-
cent, adherent, and suspended cells should only be made
within each established line.) Note that other established
markers of G1 phase cell cycle progression (induction of
cyclin D1, complete downregulation of p27kip1, phosphory-
lation of pRb, and expression of cyclin A) were adhesion
dependent in both wild-type and p21cip1-null MEFs, con-
sistent with our previous studies (Zhu et al., 1996). The ex-
pression of cyclin E and cdk2 was also similar in the wild-
type and p21cip1-null cells. Thus, the cyclin E–cdk2 kinase
activity detected in suspended p21cip1-null MEFs can be at-
tributed specifically to the loss of p21cip1. In turn, this re-
sult indicates that downregulation of p21cip1 participates in
the activation of cyclin E–cdk2. The incomplete rescue of
cyclin E–cdk2 activity in suspended p21cip1-null MEFs sup-
ports previous studies by us and others (Fang et al., 1996;
Schulze et al., 1996; Zhu et al., 1996) which indicate that
adhesion-dependent downregulation of p27kip1 also con-
tributes to the adhesion dependency of cyclin E–cdk2 ac-
tivity.
Discussion
Several studies have shown that growth factors and the
ECM cooperate to regulate cell cycle progression. Phos-
phorylation/activation of the ERKs and induction of cyclin
D1 are two well-established examples of this cooperation
(reviewed in Assoian, 1997; Giancotti, 1997; Howe et al.,
1998). These events are causally related because cyclin D1
expression is induced by sustained ERK activity (Weber
et al., 1997). Although the exact mechanisms by which
growth factors and ECM signals cooperate to regulate
ERK activity are still under investigation, it is generally
thought that the regulation of G1 phase ERK activity by
growth factors and the ECM reflects a convergence of
RTK and integrin signals upstream of ERK (Lin et al.,
1997; Renshaw et al., 1997). This convergence is important
for expression of cyclin D1 (Roovers et al., 1999). In con-
trast, our data with p21cip1 show that a strong mitogenic
stimulus is sufficient to induce p21cip1 in early G1 phase
and that cell anchorage subsequently allows for full re-
pression of p21cip1 expression in mid-late G1 phase. These
results show that growth factor/ECM cooperation involves
parallel as well as convergent signaling.
Transient Activation of ERKs Induces p21cip1 in
G1 Phase
Our results with pharmacologic inhibitors and conditional
expression of constitutively active MEK show that the ac-
tivation of ERKs plays a major role in the induction of
p21cip1 by growth factors. This effect probably contributes
to the assembly of cyclin D–cdk4/6 complexes (Cheng et
al., 1999). Indeed, a p21cip1-mediated assembly of cyclin-
cdk complexes could explain the results of Cheng et al.
(1998), which indicate that activation of the MEK/ERK
pathway is sufficient to override the mitogen requirement
for assembly of cyclin D–cdk4/6 complexes. In contrast to
the induction of cyclin D1, growth factors can induce
p21cip1 whether or not cells are attached to a substratum.
This anchorage independency of p21cip1 induction reflects
the fact that a transient activation of ERK is sufficient to
induce p21cip1. In our studies and some others (this report;
Zhu and Assoian, 1995; Renshaw et al., 1997; Clark et al.,
1998), transient ERK activation occurred in response to
growth factors and in the absence of cell adhesion. How-
ever, others have also reported that growth factors poorly
activate ERK when cells are cultured in the absence of a
substratum (e.g., Miyamoto et al., 1996; Lin et al., 1997;
Figure 7. Downregulation of p21cip1 by ECM does not require
p53 and is independent of ERK. In A, serum-starved p53-null
MEFs were cultured in monolayer (Mn) and suspension (Sp) and
analyzed by Northern blotting as described in the legend to Fig. 6
A. Equal RNA loading was confirmed by ethidium-bromide
staining of rRNA (not shown). In B, asynchronous tet-mek*-3T3
cells (2 3 106 cells per 100-mm dish) were incubated with 10 ml of
10% FCS-DME in suspension (Sp) and monolayer (Mn) for 24 h
in the absence (2) and presence (1) of tetracycline (tet). Cells
were collected and lysed for immunoblotting analysis using anti-
bodies to mek-1, ERK, phospho-ERK (p-ERK), and p21cip1. In
this experiment, lysates were fractionated on a 5–15% gradient
SDS gel that does not permit complete resolution of unphos-
phorylated and phosphorylated ERKs by gel-shift.The Journal of Cell Biology, Volume 146, 1999 1262
Renshaw et al., 1997; Short et al., 1998; Aplin and Juliano,
1999). The different results may reflect how long cells are
kept in suspension before growth factor stimulation (Ren-
shaw et al., 1997) or whether the cells have received a suf-
ficiently strong mitogenic stimulus as described in Fig. 3 C.
Others have shown that the induction of p21cip1 requires
a stronger ERK signal than does the induction of cyclin
D1 (Sewing et al., 1997; Woods et al., 1997). In agreement
with these studies, our results do show that the persistent
ERK signal seen throughout G1 phase and associated with
cyclin D1 expression is not as strong as the transient, early
G1 ERK signal associated with the induction of p21cip1.
Some studies also suggest that sustained ERK activity me-
diates the induction of p21cip1 (Pumiglia and Decker, 1997;
Auer et al., 1998), while our results show that a transient
activation is sufficient. A likely explanation for these dif-
ferent results is that most of the studies by others have re-
lied on overexpression of activated rafs, and the nature of
this experimental approach precludes an analysis of effects
mediated by transient ERK activity.
Adhesion-dependent Downregulation of p21cip1 and Its 
Independence from MAP Kinase
Our data also suggest that the effect of cell anchorage on
mid-late G1 repression of p21cip1 gene expression is impor-
tant for cell cycle progression. We and others have previ-
ously reported that p21cip1 and p27kip1 levels increase when
fibroblasts are cultured with mitogens in suspension, and
this increase in CKIs is associated with inactivity of the cy-
clin E–cdk2 complex. Cyclin E–cdk2 is partially anchorage
independent in cells lacking p21cip1, implying that down-
regulation of p21cip1 in normal cells contributes to the acti-
vation of cyclin E–cdk2. The increased expression of
p21cip1 in suspended cells has typically been interpreted as
an induction, but the results shown here indicate that im-
paired downregulation of p21cip1 is the proper explanation.
Brugarolas et al. (1998) have also examined the effect of
p21cip1 on the anchorage dependency of cyclin E–cdk2 ac-
tivity. Consistent with our results, they found that cyclin
E–cdk2 activity in suspended pRb/p21cip1-null MEFs was
higher than that in wild-type MEFs. However, we found
that cyclin E–cdk2 activity in suspended p21cip1-null MEFs
was half of that seen in the adherent p21cip1-null MEFs
while they reported that the cyclin E–cdk2 activity of sus-
pended pRb/p21cip1-null cells was only 20% of that ob-
served with adherent pRb/p21cip1-null cells. The difference
between their results and ours may reflect the fact that our
analysis was performed with cells in the first G1 phase
while their studies used cells incubated in suspension for
three days before analysis. The cell cycle blocks in their
system and ours may be of a different nature and not di-
rectly comparable. Moreover, we can not exclude the pos-
sibility that the pRb-null phenotype of the MEFs used by
Brugarolas et al. (1998) may also contribute to the differ-
ent results.
There is precedent for negative regulation of p21cip1 pro-
tein by rho (Olson et al., 1998). Negative regulatory motifs
have also been mapped to the 39 untranslated region in the
p21cip1 mRNA (Rishi et al., 1997). Downregulation of the
p21cip1 promoter may also be specific to positional cues in
the cell cycle because the p21cip1 promoter is downregu-
lated in mid-late G1; cells treated with mitogens in suspen-
sion fail to reach mid-late G1 (Schwartz et al., 1991; Böh-
mer et al., 1996). The effect of cell anchorage on these
different modes of regulation remains to be elucidated.
Importantly, the downregulation of p21cip1 observed in re-
sponse to cell adhesion is independent of ERK activity
and can even occur in the presence of a sustained ERK
signal. This allows the cell to fully downregulate p21cip1 ex-
pression in the presence of the sustained ERK signal
needed for the induction of cyclin D1.
Several laboratories have shown that high-intensity raf
signals induce p21cip1 and also result in a p21cip1-dependent
cell cycle arrest (Lloyd et al., 1997; Pumiglia and Decker,
1997; Sewing et al., 1997; Woods et al., 1997; Auer et al.,
1998). As discussed above, the induction of p21cip1 by raf is
probably the result of ERK activation and is consistent
with our studies. The persistently elevated expression of
p21cip1 characteristic of cell cycle arrest in high intensity raf
Figure 8. p21cip1 is important for the anchorage
dependency of cyclin E–cdk2 activity. G0-syn-
chronized (G0) MEFs from wild-type (p211/1)
and p21cip1-null (p212/2) mice were trypsinized,
reseeded in suspension (Sp) and monolayer
(Mn), and incubated in 10% FCS-DME for 18 h.
The cells were collected and lysed. Equal
amounts of cellular protein (200 mg) were loaded
on a reducing SDS gradient gel (5–15% acryl-
amide) and analyzed by immunoblotting with an-
tibodies to cyclin E, p21cip1, p27kip1, cdk2, cyclin
D1, pRb, cyclin A, and cdk4. The immunoreac-
tive proteins were visualized by ECL. The upper
and lower arrows on the pRb blot show the phos-
phorylated and hypophosphorylated pRb, re-
spectively. Duplicate aliquots of 200 mg from the
same experiment were incubated with anti-cyclin E in order to collect cyclin E–cdk2 complexes for determination of cyclin E–cdk2 ki-
nase activity in vitro using histone H1 as substrate as described (Zhu et al., 1996). p212/2 MEFs progressed through G1 phase several
hours faster than p211/1 MEFs (data not shown), and the difference in cyclin E–cdk2 kinase activity detected in monolayer cultures of
p211/1 cells vs. p212/2 cells most likely reflects the fact that the two lines were not in identical positions within G1 phase when as-
sayed 18 h after exposure to mitogens.Bottazzi et al. Regulation of p21cip1 Expression 1263
transformants suggests that overexpression of constitu-
tively activated raf can override the normal ERK-indepen-
dent signaling mechanism(s) that control the mid-late G1
phase downregulation of p21cip1 by the extracellular ma-
trix.
Integrated Growth Factor and ECM-dependent 
Signaling and Its Consequence for Cyclin D1, p21cip1, 
and Cell Cycle Progression through G1 Phase
While others have shown that sustained ERK activation is
required for cell cycle progression, our results indicate that
transient ERK activation is not without effect. Rather, we
propose that transient ERK activity results in the induc-
tion of p21cip1 while sustained ERK activity, mediated by
growth factor/ECM cooperation, and results in the induc-
tion of cyclin D1 (Fig. 9). The induction of p21cip1 and cy-
clin D1 are both important for the assembly of cyclin
D–cdk4/6 complexes (LaBaer et al., 1997; Cheng et al.,
1999). In addition, p21cip1 inhibits cyclin E–cdk2; our re-
sults indicate that full downregulation of p21cip1 gene ex-
pression requires cell adhesion to ECM and that this effect
contributes to the control of cyclin E–cdk2 activity.
The importance of p21cip1 in regulating adhesion-depen-
dent G1 phase progression is highlighted by the study of
Brugarolas et al. (1998) which showed that MEFs null for
pRb (the only essential substrate for cyclin D1-cdk4/6; Lu-
kas et al., 1995) and p21cip1 are anchorage-independent for
growth. Nevertheless, several studies do indicate that
ECM-dependent regulation of p27kip1 also plays a role in
regulating cyclin E–cdk2 activity. p27kip1 levels are typi-
cally regulated posttranscriptionally, and ubiquitin-medi-
ated degradation is thought to play a critical role in this
process (see introduction). Thus, the mechanism by which
the ECM controls the steady state expression of p27kip1 is
likely to be very different from that of p21cip1 and an inter-
esting matter for investigation.
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